The Physiologic Assessment of Exercise Capacity in Pediatric Sickle Cell Anemia
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- VO2 max on cardiopulmonary exercise test
研究概览
简要总结
The purpose of this study is to use comprehensive exercise testing to examine causes of exercise limitation in children and young adults with sickle cell anemia.
详细描述
Although the burden of sickle cell anemia (SCA) on affected individuals is significant, few studies have examined the influence of having SCA on such measures of physical function as exercise capacity. Moreover, the physiologic basis of poor physical functioning in children with SCA is unknown and has not been studied extensively. The purpose of this proposal is to use cardiopulmonary exercise testing (CPET) to gain a comprehensive understanding of exercise capacity, as a measure of physical function, in children and young adults with SCA. The specific aims of this project are to: 1) Measure peak oxygen consumption (VO2), the reference standard for exercise capacity, in children and young adults with SCA classified by primary pathophysiologic contributor to their decreased exercise capacity, and 2) Examine the acute inflammatory response, measured by an increase in soluble vascular cell adhesion molecule (sVCAM) activity, in subjects undergoing CPET. These aims will be performed in 60 subjects with SCA and 30 matched controls without SCA. In a secondary analysis, we will also study the impact of baseline exercise capacity and the inflammatory response to exercise on short and long-term disease related morbidity. This study is essential because it will address several areas of exercise capacity, including the physiologic contributors to exercise limitation that remain fundamental knowledge gaps in SCA.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 8 Years 至 21 Years(Child, Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •age 10 to 21 years old; AND
- •Hb SS or S-β0 thalassemia disease, confirmed by hemoglobin analysis
排除标准
- •inability to perform maximal testing due to physical limitation (e.g. stroke or avascular necrosis); OR
- •history of exercise-induced syncope or arrhythmias. Subjects will wait at least 2 weeks following any vaso-occlusive pain episode and 12 weeks following any disease-related complication requiring transfusion support. Individuals on hydroxyurea will be eligible. A total of 30 controls without SCA or sickle cell trait will be matched for age, sex and race and recruited from the siblings, friends or relatives of subjects enrolled on this study
结局指标
主要结局
VO2 max on cardiopulmonary exercise test
时间窗: Baseline
次要结局
- Change in VCAM level in response to exercise testing(Baseline (pre-exercise) and Post-exercise)
- Skin fold measurements to detemine percent body fat(Baseline)
- All patient reported pain episodes(Every 2 months up to 2 years after baseline)
- Change in secondary biomarkers in response to exercise test(Baseline (Pre-exercise) and Post-exercise)
研究者
Robert I. Liem
Attending Physician, Hematology, Oncology,Cell Transplantation
Ann & Robert H Lurie Children's Hospital of Chicago
